Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1530/EJE-20-0377 http://scihub22266oqcxt.onion/10.1530/EJE-20-0377 32508313!7938018!32508313     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 269.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Endocrinol 2020 ; 183 (2): G67-G77 Nephropedia Template TP {{tp|p=32508313|t=2020. ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation |pdf=|usr=}}{{32508313}} gab.com Text ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation JO: Eur J Endocrinol http://www.kidney.de/pget.php?&tw=1&pmid=32508313 #FOAvip The COVID-19 pandemic is a major international emergency leading to unprecedented medical, economic and societal challenges. Countries around the globe are facing challenges with diabetes care and are similarly adapting care delivery, with local cultural nuances. People with diabetes suffer disproportionately from acute COVID-19 with higher rates of serious complications and death. In-patient services need specialist support to appropriately manage glycaemia in people with known and undiagnosed diabetes presenting with COVID-19. Due to the restrictions imposed by the pandemic, people with diabetes may suffer longer-term harm caused by inadequate clinical support and less frequent monitoring of their condition and diabetes-related complications. Outpatient management need to be reorganised to maintain remote advice and support services, focusing on proactive care for the highest risk, and using telehealth and digital services for consultations, self-management and remote monitoring, where appropriate. Stratification of patients for face-to-face or remote follow-up should be based on a balanced risk assessment. Public health and national organisations have generally responded rapidly with guidance on care management, but the pandemic has created a tension around prioritisation of communicable vs non-communicable disease. Resulting challenges in clinical decision-making are compounded by a reduced clinical workforce. For many years, increasing diabetes mellitus incidence has been mirrored by rising preventable morbidity and mortality due to complications, yet innovation in service delivery has been slow. While the current focus is on limiting the terrible harm caused by the pandemic, it is possible that a positive lasting legacy of COVID-19 might include accelerated innovation in chronic disease management. Twit Text FOAVip ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation ????Eur J Endocrinol http://www.kidney.de/pget.php?&tw=1&pmid=32508313 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32508313 #FOAvip English Wikipedia <ref>{{Cite pmid|32508313}}</ref> ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation #MMPMID32508313 Wake DJ; Gibb FW; Kar P; Kennon B; Klonoff DC; Rayman G; Rutter MK; Sainsbury C; Semple RK Eur J Endocrinol 2020[Aug]; 183 (2): G67-G77 PMID32508313show ga The COVID-19 pandemic is a major international emergency leading to unprecedented medical, economic and societal challenges. Countries around the globe are facing challenges with diabetes care and are similarly adapting care delivery, with local cultural nuances. People with diabetes suffer disproportionately from acute COVID-19 with higher rates of serious complications and death. In-patient services need specialist support to appropriately manage glycaemia in people with known and undiagnosed diabetes presenting with COVID-19. Due to the restrictions imposed by the pandemic, people with diabetes may suffer longer-term harm caused by inadequate clinical support and less frequent monitoring of their condition and diabetes-related complications. Outpatient management need to be reorganised to maintain remote advice and support services, focusing on proactive care for the highest risk, and using telehealth and digital services for consultations, self-management and remote monitoring, where appropriate. Stratification of patients for face-to-face or remote follow-up should be based on a balanced risk assessment. Public health and national organisations have generally responded rapidly with guidance on care management, but the pandemic has created a tension around prioritisation of communicable vs non-communicable disease. Resulting challenges in clinical decision-making are compounded by a reduced clinical workforce. For many years, increasing diabetes mellitus incidence has been mirrored by rising preventable morbidity and mortality due to complications, yet innovation in service delivery has been slow. While the current focus is on limiting the terrible harm caused by the pandemic, it is possible that a positive lasting legacy of COVID-19 might include accelerated innovation in chronic disease management. |*Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/diagnosis/*epidemiology/*therapy[MESH] |Diabetes Mellitus/diagnosis/*epidemiology/*therapy[MESH] |Endocrinology/methods/trends[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*epidemiology/*therapy[MESH] |SARS-CoV-2[MESH] |Telemedicine/methods/trends[MESH] |Therapies, Investigational/methods/*trends[MESH]ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services a(epmc).pdf DeepDyve Pubget Overpricing